Zoetis (ZTS) PT Set at $78.00 by BMO Capital Markets

BMO Capital Markets set a $78.00 target price on Zoetis (NYSE:ZTS) in a report issued on Thursday morning. The brokerage currently has a hold rating on the stock.

A number of other equities analysts have also issued reports on the company. Zacks Investment Research lowered Zoetis from a hold rating to a sell rating and set a $83.00 price target on the stock. in a report on Saturday, January 13th. Morgan Stanley raised Zoetis from an equal weight rating to an overweight rating and set a $80.00 price target on the stock in a report on Wednesday, November 29th. Jefferies Group reissued a buy rating on shares of Zoetis in a report on Friday, November 10th. Craig Hallum reissued a buy rating and set a $85.00 price target (up previously from $77.00) on shares of Zoetis in a report on Tuesday, January 2nd. Finally, BidaskClub raised Zoetis from a hold rating to a buy rating in a report on Tuesday, November 7th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fourteen have given a buy rating to the company. The company has a consensus rating of Buy and an average price target of $80.00.

Zoetis (NYSE ZTS) opened at $79.73 on Thursday. The company has a current ratio of 2.80, a quick ratio of 1.95 and a debt-to-equity ratio of 2.45. Zoetis has a twelve month low of $52.25 and a twelve month high of $81.40. The stock has a market capitalization of $38,850.00, a PE ratio of 36.57, a P/E/G ratio of 1.69 and a beta of 1.07.

Zoetis (NYSE:ZTS) last released its quarterly earnings results on Thursday, February 15th. The company reported $0.69 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.66 by $0.03. Zoetis had a return on equity of 65.83% and a net margin of 16.28%. The firm had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.40 billion. During the same quarter last year, the company posted $0.47 earnings per share. The business’s revenue was up 14.3% on a year-over-year basis. analysts expect that Zoetis will post 3.01 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 1st. Shareholders of record on Friday, April 20th will be issued a $0.126 dividend. This represents a $0.50 dividend on an annualized basis and a yield of 0.63%. The ex-dividend date of this dividend is Thursday, April 19th. Zoetis’s dividend payout ratio is presently 22.94%.

Institutional investors and hedge funds have recently made changes to their positions in the business. Dynamic Technology Lab Private Ltd lifted its position in shares of Zoetis by 7.3% during the 2nd quarter. Dynamic Technology Lab Private Ltd now owns 5,901 shares of the company’s stock valued at $368,000 after acquiring an additional 401 shares during the period. Robecosam AG lifted its position in shares of Zoetis by 4.6% during the 4th quarter. Robecosam AG now owns 15,346 shares of the company’s stock valued at $1,111,000 after acquiring an additional 679 shares during the period. Daiwa Securities Group Inc. lifted its position in shares of Zoetis by 4.3% during the 4th quarter. Daiwa Securities Group Inc. now owns 16,828 shares of the company’s stock valued at $1,212,000 after acquiring an additional 697 shares during the period. Sandy Spring Bank lifted its position in shares of Zoetis by 2.3% during the 4th quarter. Sandy Spring Bank now owns 31,018 shares of the company’s stock valued at $2,235,000 after acquiring an additional 708 shares during the period. Finally, Penserra Capital Management LLC lifted its position in shares of Zoetis by 18.6% during the 4th quarter. Penserra Capital Management LLC now owns 4,550 shares of the company’s stock valued at $327,000 after acquiring an additional 715 shares during the period. 93.72% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION NOTICE: “Zoetis (ZTS) PT Set at $78.00 by BMO Capital Markets” was originally published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of US & international copyright laws. The correct version of this piece of content can be viewed at https://stocknewstimes.com/2018/02/18/zoetis-zts-pt-set-at-78-00-by-bmo-capital-markets.html.

About Zoetis

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

Analyst Recommendations for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply